Clinical Cases in Acute Intoxication

References

• Bronstein AC, Spyker DA, Cantilena LR Jr, Green JL, Rumack BH, Heard SE; American Association of Poison Control Centers. 2007 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th Annual Report. Clin Toxicol (Phila). 2008; 46(10): 927–1057.
   Google Scholar
• Proudfoot A. Practical management of the poisoned patient. Abstract. Therapeutic Drug Monitoring. 1998; 20(5): 498–501.
   PubMedGoogle Scholar
• Brent J. Current management of ethylene glycol poisoning. Drugs. 2001; 61(7): 979–988.
   PubMedGoogle Scholar
• Barceloux DG, Krenzelok EP, Olson K, Watson W. American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning. Ad Hoc Committee. J Toxicol Clin Toxicol. 1999; 37(5): 537–560.
   PubMed Web of Science ®Google Scholar
• Mégarbane SW, Borron SW, Baud FJ. Current recommendations for treatment of severe toxic alcohol poisonings. Intensive Care Med. 2005; 31 (2): 189–195.
   PubMed Web of Science ®Google Scholar
• Rowden AK, Norvell J, Eldridge DL, Kirk MA. Acetaminophen poisoning. Clin Lab Med. 2006; 26(1): 49–65, viii.
   PubMed Web of Science ®Google Scholar
• Kanter MZ. Comparison of oral and i.v. acetylcysteine in the treatment of acetaminophen poisoning. Am J Health Syst Pharm. 2006; 63(19): 1821–1827.
   PubMed Web of Science ®Google Scholar
• Chun LJ, Tong MJ, Busuttil RW, Hiatt JR. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol. 2009; 43(4): 342–349.
   PubMed Web of Science ®Google Scholar
• Smilkstein MJ, Knapp GL, Kulig KW, Rumack BH. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988; 319(24): 1557–1562.
   PubMed Web of Science ®Google Scholar
• Harrison PM, Keays R, Bray GP, Alexander GJ, Williams R. Improved outcome of paracetamol-induced fulminant hepatic failure by late administration of acetylcysteine. Lancet. 1990; 335(8705): 1572–1573.
   PubMedGoogle Scholar
• Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809): 1026–1029.
   PubMed Web of Science ®Google Scholar
• Kociancic T, Reed MD. Acetaminophen intoxication and length of treatment: how long is long enough? Pharmacotherapy. 2003; 23(8): 1052–1059.
   PubMed Web of Science ®Google Scholar
• Rumack BH, Matthew H. Acetaminophen poisoning and toxicity. Pediatrics. 1975; 55(6): 871–876.
   PubMed Web of Science ®Google Scholar
• O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989; 97(2): 439–445.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Overdose deaths involving prescription opioids among Medicaid enrollees—Washington, 2004–2007. MMWR Morb Mortal Wkly Rep. 2009; 58(42): 1171–1175.
   PubMedGoogle Scholar
• Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008; 300(22): 2613–2620.
   PubMed Web of Science ®Google Scholar
• Watson WA, Litovitz TL, Rodgers GC Jr, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2005; 23(5): 589–666.
   Google Scholar
• Wunsch MJ, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: a description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict. 2009; 18(1): 5–14.
   PubMed Web of Science ®Google Scholar
• Waldhoer M, Bartlett SE, Whistler JL. Opioid receptors. Annu Rev Biochem. 2004; 73: 953–990.
   PubMed Web of Science ®Google Scholar
• Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage. 2004; 28(5): 497–504.
   PubMed Web of Science ®Google Scholar
• Guay DR, Awni WM, Findlay JW, et al. Pharmacokinetics and pharmacodynamics of codeine in end-stage renal disease. Clin Pharmacol Ther. 1988; 43(1): 63–71.
   PubMed Web of Science ®Google Scholar
• Raehal KM, Bohn LM. Mu opioid receptor regulation and opiate responsiveness. AAPS. 2005; 7(3): E587–E591.
   Google Scholar
• Buajordet I, Naess AC, Jacobsen D, Brors O. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med. 2004; 11(1): 19–23.
   PubMed Web of Science ®Google Scholar
• Clarke SF, Dargan PI, Jones AL. Naloxone in opioid poisoning: walking the tightrope. Emerg Med J. 2005; 22(9): 612–616.
   PubMed Web of Science ®Google Scholar
• Ling W. Buprenorphine for opioid dependence. Expert Rev Neurother. 2009; 9(5): 609–616.
   PubMed Web of Science ®Google Scholar
• Sporer KA. Buprenorphine: a primer for emergency physicians. Ann Emerg Med. 2004; 43(5): 580–584.
   PubMed Web of Science ®Google Scholar
• Harrigan RA, Brady WJ. ECG abnormalities in tricyclic antidepressant ingestion. Am J Emerg Med. 1999; 17(4): 387–393.
   PubMed Web of Science ®Google Scholar
• Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001; 18(4): 236–241.
   PubMed Web of Science ®Google Scholar
• Crome P. Poisoning due to tricyclic antidepressant overdosage. Clinical presentation and treatment. Med Toxicol. 1986; 1(4): 261–285.
   PubMedGoogle Scholar
• Foulke GE. Identifying toxicity risk early after antidepressant overdose. Am J EmergMed. 1995; 13(2): 123–126.
   PubMedGoogle Scholar
• Hedges JR, Otten EJ, Schroeder TJ, Tasset JJ. Correlation of initial amitriptyline concentration reduction with activated charcoal therapy in overdose patients. Am J Emerg Med. 1987; 5(1): 48–51.
   PubMed Web of Science ®Google Scholar
• Bosse GM, Barefoot JA, Pfeifer MP, Rodgers GC. Comparison of three methods of gut decontamination in tricyclic antidepressant overdose. J Emerg Med. 1995; 13(2): 203–209.
   PubMedGoogle Scholar
• Crome P, Adams R, Ali C, Dallos V, Dawling S. Activated charcoal in tricyclic antidepressant poisoning: pilot controlled clinical trial. Hum Toxicol. 1983; 2(2): 205–209.
   PubMedGoogle Scholar
• Hulten BA, Adams R, Askenasi R, et al. Activated charcoal in tricyclic antidepressant poisoning. Hum Toxicol. 1988; 7(4): 307–310.
   PubMedGoogle Scholar
• Glauser J. Tricyclic antidepressant poisoning. Cleve Clin J Med. 2000; 67(10): 704–706, 709–713, 717–719.
   PubMedGoogle Scholar
• Liebelt EL, Francis PD, Woolf AD. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med. 1995; 26(2): 195–201.
   PubMed Web of Science ®Google Scholar
• Bradberry SM, Thanacoody HK, Watt BE, Thomas SH, Vale JA. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate. Toxicol Rev. 2005; 24(3): 195–204.
   PubMedGoogle Scholar
• Knudsen K, Abrahamsson J. Epinephrine and sodium bicarbonate independently and additively increase survival in experimental amitriptyline poisoning. Crit Care Med. 1997; 25(4): 669–674.
   PubMedGoogle Scholar
• Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the coronary arteries. Am Heart J. 2001; 142(3): 402–410.
   PubMed Web of Science ®Google Scholar
• Lange RA, Cigarroa JE, Hillis LD. Theodore E. Woodward award: cardiovascular complications of cocaine abuse. Trans Am Clin Climatol Assoc. 2004; 115: 99–111.
   PubMedGoogle Scholar
• Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009; 9(3): 177–196.
   PubMedGoogle Scholar
• Lange RA, Cigarroa RG, Yancy C W Jr, et al. Cocaine-induced coronaryartery vasoconstriction. N Engl J Med. 1989; 321(23): 1557–1562.
   PubMed Web of Science ®Google Scholar
• Mo W, Singh AK, Arruda JA, Dunea G. Role of nitric oxide in cocaine-induced acute hypertension. Am J Hypertens. 1998; 11 (6 pt 1): 708–714.
   PubMed Web of Science ®Google Scholar
• Wilbert-Lampen U, Seliger C, Zilker T, Arendt RM. Cocaine increases the endothelial release of immunoreactive endothelin and its concentrations in human plasma and urine: reversal by coincubation with sigma-receptor antagonists. Circulation. 1998; 98(5): 385–390.
   PubMedGoogle Scholar
• Moliterno DJ, Lange RA, Gerard RD, Willard JE, Lackner C, Hillis LD. Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med. 1994; 96(6): 492–496.
   PubMedGoogle Scholar
• Siegel AJ, Mendelson JH, Sholar MB, et al. Effect of cocaine usage on C-reactive protein, von Willebrand factor, and fibrinogen. Am J Cardiol. 2002; 89(9): 1133–1135.
   PubMedGoogle Scholar
• Hollander JE, Henry TD. Evaluation and management of the patient who has cocaine-associated chest pain. Cardiol Clin. 2006; 24(1): 103–114.
   PubMedGoogle Scholar
• McCord J, Jneid H, Hollander JE, et al; American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation. 2008; 117(14): 1897–1907.
   PubMed Web of Science ®Google Scholar
• Lange RA, Cigarroa RG, Flores ED, et al. Potentiation of cocaine-induced coronary vasoconstriction by beta-adrenergic blockade. Ann Intern Med. 1990; 112(12): 897–903.
   PubMed Web of Science ®Google Scholar